PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Clinical trials for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR t therapy trial hopes to tackle tough leukemia in kids
Disease control Recruiting nowThis early-stage trial is testing a type of immunotherapy called CAR T cells in children, adolescents, and young adults with acute lymphoblastic leukemia that has come back or not responded to standard treatments. The study will use two different CAR T products based on the patie…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 23, 2026 22:17 UTC
-
Experimental CART123 therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a personalized cell therapy called CART123 for people with certain blood cancers (like AML or MDS) that have not responded to standard treatments. Each patient's own immune cells are modified in a lab to recognize and attack cancer cells. The main goa…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Experimental drug TURALIO takes on tough childhood cancers in early trial
Disease control Recruiting nowThis early-phase study tests the drug TURALIO (pexidartinib) in people aged 3 to 35 whose cancer has not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors or control leukemia. Participants take a daily capsule for up to 2 years, wit…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
New combo therapy aims to boost leukemia remission with fewer side effects
Disease control Recruiting nowThis study tests a combination of low-dose chemotherapy and immune-targeted drugs in adults newly diagnosed with Ph-negative B-cell acute lymphoblastic leukemia. The goal is to see if this gentler approach can clear cancer cells from the bone marrow and improve long-term survival…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
Virtual play therapy aims to boost motor skills and social life in young leukemia survivors
Symptom relief Recruiting nowThis study tests a 12-week virtual buddy-movement therapy for children aged 5 to 12 who have finished treatment for acute lymphoblastic leukemia. The program pairs each child with a healthy buddy for twice-weekly movement sessions designed to improve motor skills, coordination, a…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: NA • Sponsor: Comenius University • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC